( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



Syeda Batool*, Syeda Juveria Sultana, Md. Yousuf Hussain, J. Sai Prakash, Dr. Kanchana N. Dussa and Dr. Mehraj Unnisa


Background: Cardiovascular diseases are a major health problem and have become the world’s most common cause of morbidity and mortality. Prescription Pattern Monitoring Studies are the Drug Utilization Studies that help to evaluate the problems in prescribing patterns. Thus, the study aimed to assess the prescribing pattern of drugs in patients with cardiovascular diseases. Materials and Methods: A Prospective observational study was conducted from July 2018 to March 2019 in the In-Patient Department of Cardiology in a tertiary care hospital, Hyderabad. The demographic and treatment data of 196 patients were collected in a specially designed data collection form. WHO prescribing indicators and other parameters were analyzed using descriptive statistics to measure the performance of health care providers related to the appropriate use of drugs. Results: In this study, among 196 patients, 65.82% and 34.18% were males and females respectively. A maximum number of patients was in the age group of 51-60 years (33.67%). Most commonly prescribed cardiovascular single drugs, 25.93% were anti-hypertensives followed by 22.70% of antiplatelets. The most commonly prescribed cardiovascular FDCs were a combination of two Antihypertensive drugs (50.94%) followed by a combination of Antihyperlipidemic and Antiplatelet drugs (21.70%). The average number of drugs per prescription was 9.96. Antibiotics were prescribed to 34.18% patients and injections were prescribed to 75% of patients. Cardiovascular drugs prescribed from the 2017 WHO model list of essential mediates was 35.81%. Among drug-drug interactions, moderate interactions were most commonly found followed by major interactions. Conclusion: Present study results conclude that pharmacists and prescribers should collaborate to improve prescribing patterns and help promote rational drug use.

Keywords: Rational use, prescription pattern, WHO prescribing indicators, cardiovascular drugs, polypharmacy, drug-drug interactions.

[Full Text Article]




    December issue has been successfully launched on December 2023.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2023 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia